A significant share of Canadians with diabetes struggle to keep their glucose levels in check, a worrying trend given the growing prevalence of diabetes in the country. Roughly 75 per cent of Canadians who use insulin to manage their diabetes — and 40 per cent of those who don’t — aren’t hitting their glucose targets, […]
Innovative Medicines Canada is calling on the federal government to introduce amendments to Bill C-64 that clarify the impact on all aspects of Canadians’ drug coverage. In a press release, the association urged the feds to ensure its new pharmacare program doesn’t disrupt existing coverage for the 27 million Canadians who are insured under a […]
During a panel discussion at Benefits Canada’s 2024 Vancouver Benefits Summit in May, three experts discussed the role of virtual management platforms in helping Canadians with diabetes manage their condition. According to Diabetes Canada, roughly 12 million Canadians live with type 1, type 2 or prediabetes. Roughly a quarter of Canadians don’t have access to […]
An article on the benefits of tailoring an individual’s work schedule around their circadian rhythm and optimum times of productivity was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the last week: 1. How ‘Chronoworking’ is helping boost employee productivity, recruitment 2. FSRA releases final […]
Roughly a third (34 per cent) of employers in the U.S. are providing coverage for glucagon-like peptide-1 medications for both diabetes care and weight-loss management in 2024, up from 26 per cent in 2023, according to a new survey by the International Foundation of Employee Benefit Plans. However, the survey, which polled more than 270 U.S. employers, found more […]
Institutional investors are navigating two massive innovations, namely artificial intelligence and artificial incretins, said Jennifer O’Hara Martin, global equity portfolio specialist at T. Rowe Price, during the Canadian Investment Review‘s 2024 Global Investment Conference in April. People tend to compare the current AI trend to the technology bubble of the 2000s and while its infrastructure is similar, […]
The use of obesity medications among Canadian employer-sponsored benefits plan members has grown substantially, with claims increasing 42 per cent in 2023 and roughly 92 per cent since 2020, according to a new report by Manulife Financial Corp. The report, based on aggregate claims data, found more women are using obesity drugs than men (79 […]
In its 2024 budget on Tuesday, the federal government announced a new working group dedicated to encouraging increased domestic investments by Canadian institutional investors. Former Bank of Canada governor Stephen Poloz is being tasked to lead an organization that will identify priority investment opportunities in the country for the more than $3 trillion held by […]
Health Minister Mark Holland tabled a long-awaited bill Thursday meant to pave the way for national pharmacare and preserve a deal that secures the New Democratic Party’s support for the government in the House of Commons. The bill includes a program to cover birth control as well as diabetes drugs and supplies for anyone with […]
U.S. employers say they’re expecting their total health benefits plan costs to rise by an average of 5.4 per cent per employee in 2024, according to a new survey by Mercer. The survey, which polled more than 1,900 employers, found the projected increase comes after more than a decade of annual cost increases typically averaging […]